{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:56:47Z","timestamp":1790758607888,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T00:00:00Z","timestamp":1369958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063798","type":"journal-article","created":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T04:50:01Z","timestamp":1370062201000},"page":"e63798","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis"],"prefix":"10.1371","volume":"8","author":[{"given":"Ajit A.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Min","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Matthew","family":"Kottmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Morrissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry W.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Sime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1440-1843.2009.01624.x","article-title":"Determinants of initiation and progression of idiopathic pulmonary fibrosis","volume":"14","author":"RM Kottmann","year":"2009","journal-title":"Respirology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1164\/rccm.200608-1153CC","article-title":"Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots","volume":"175","author":"SD Nathan","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"71","author":"P Camus","year":"2004","journal-title":"Respiration"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-5231(03)00123-0","article-title":"Chemotherapy-induced lung disease","volume":"25","author":"AH Limper","year":"2004","journal-title":"Clin Chest Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/annonc\/mdj057","article-title":"Pulmonary toxicity from novel antineoplastic agents","volume":"17","author":"I Dimopoulou","year":"2006","journal-title":"Ann Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/11591490-000000000-00000","article-title":"New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis","volume":"71","author":"Q Ding","year":"2011","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1124\/pr.111.004846","article-title":"Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease","volume":"64","author":"KT Liby","year":"2012","journal-title":"Pharmacol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/jir.2009.0100","article-title":"The synthetic triterpenoid, CDDO-Me, modulates the proinflammatory response to in vivo lipopolysaccharide challenge","volume":"30","author":"JJ Auletta","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1165\/rcmb.2009-0006OC","article-title":"Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts","volume":"41","author":"HE Ferguson","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e15909","DOI":"10.1371\/journal.pone.0015909","article-title":"PPAR-gamma ligands repress TGFbeta-induced myofibroblast differentiation by targeting the PI3K\/Akt pathway: implications for therapy of fibrosis","volume":"6","author":"AA Kulkarni","year":"2011","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"L1146","DOI":"10.1152\/ajplung.00383.2004","article-title":"PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis","volume":"288","author":"HA Burgess","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"L412","DOI":"10.1152\/ajplung.00392.2007","article-title":"High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function","volume":"295","author":"TH Thatcher","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/01902140600817465","article-title":"Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation","volume":"32","author":"HF Lakatos","year":"2006","journal-title":"Exp Lung Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1164\/rccm.201101-0013OC","article-title":"Transglutaminase 2 and its role in pulmonary fibrosis","volume":"184","author":"KC Olsen","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1172\/JCI6688","article-title":"Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia","volume":"104","author":"TW Wright","year":"1999","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4049\/jimmunol.0901864","article-title":"Anti-CD3 antibody decreases inflammation and improves outcome in a murine model of Pneumocystis pneumonia","volume":"184","author":"SP Bhagwat","year":"2010","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1021\/np100826q","article-title":"New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress","volume":"74","author":"MB Sporn","year":"2011","journal-title":"J Nat Prod"},{"key":"ref18","first-page":"31","article-title":"CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells","volume":"7","author":"D Deeb","year":"2008","journal-title":"J Exp Ther Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1158\/0008-5472.CAN-06-4534","article-title":"The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A\/J mice","volume":"67","author":"K Liby","year":"2007","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood.V99.1.326","article-title":"Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia","volume":"99","author":"M Konopleva","year":"2002","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"A Moeller","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2007-0299OC","article-title":"Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice","volume":"38","author":"F Saito","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/PL00021246","article-title":"Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury","volume":"180","author":"M Kawashima","year":"2002","journal-title":"Lung"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/01902149209020649","article-title":"Lung cytokine production in bleomycin-induced pulmonary fibrosis","volume":"18","author":"SH Phan","year":"1992","journal-title":"Exp Lung Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1165\/rcmb.2008-0487OC","article-title":"Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases","volume":"42","author":"JA Vanoirbeek","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1155\/2011\/354325","article-title":"Normal expiratory flow rate and lung volumes in patients with combined emphysema and interstitial lung disease: a case series and literature review","volume":"18","author":"KL Heathcote","year":"2011","journal-title":"Can Respir J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1378\/chest.10-2572","article-title":"Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium","volume":"140","author":"SD Nathan","year":"2011","journal-title":"Chest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-5231(21)00668-7","article-title":"Bleomycin-induced pulmonary toxicity","volume":"11","author":"K Jules-Elysee","year":"1990","journal-title":"Clin Chest Med"},{"key":"ref29","first-page":"508","article-title":"Pulmonary toxicity of antineoplastic therapy","volume":"19","author":"H Kreisman","year":"1992","journal-title":"Semin Oncol"},{"key":"ref30","first-page":"336","article-title":"A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity","volume":"59","author":"N Suh","year":"1999","journal-title":"Cancer Res"},{"key":"ref31","first-page":"2798","article-title":"The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo","volume":"9","author":"AE Place","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.bmcl.2010.02.007","article-title":"2-Cyano-3,10-dioxooleana-1,9(11)-dien-28-oic acid anhydride. A novel and highly potent anti-inflammatory and cytoprotective agent","volume":"20","author":"T Honda","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"318134","DOI":"10.1155\/2011\/318134","article-title":"Electrophilic PPARgamma Ligands Attenuate IL-1beta and Silica-Induced Inflammatory Mediator Production in Human Lung Fibroblasts via a PPARgamma-Independent Mechanism","volume":"2011","author":"CM Hogan","year":"2011","journal-title":"PPAR Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbrc.2006.10.102","article-title":"Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide","volume":"351","author":"RK Thimmulappa","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/rccm.200905-0670OC","article-title":"The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice","volume":"180","author":"NM Reddy","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-540-69297-3_19","article-title":"Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids","volume":"181","author":"I Sogno","year":"2009","journal-title":"Recent Results Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"PE Pergola","year":"2011","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1042\/BST0350661","article-title":"TGF-beta, Smad3 and the process of progressive fibrosis","volume":"35","author":"J Gauldie","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"TA Wynn","year":"2008","journal-title":"J Pathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","article-title":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms","volume":"187","author":"S Mi","year":"2011","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent","volume":"207","author":"MS Wilson","year":"2010","journal-title":"J Exp Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI12568","article-title":"Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis","volume":"107","author":"M Kolb","year":"2001","journal-title":"J Clin Invest"},{"key":"ref43","first-page":"1550","article-title":"A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma","volume":"14","author":"Y Wang","year":"2000","journal-title":"Mol Endocrinol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"L891","DOI":"10.1152\/ajplung.00333.2007","article-title":"PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis","volume":"294","author":"JE Milam","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/705352","article-title":"Emerging PPAR\u03b3-Independent Role of PPAR\u03b3 Ligands in Lung Diseases","volume":"2012","author":"A Kulkarni","year":"2012","journal-title":"PPAR Research"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0360-3016(79)90761-2","article-title":"Pulmonary toxicity after radiation and bleomycin: a review","volume":"5","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI119590","article-title":"Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung","volume":"100","author":"PJ Sime","year":"1997","journal-title":"J Clin Invest"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T15:15:29Z","timestamp":1645629329000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063798"}},"subtitle":[],"editor":[{"given":"Bernhard","family":"Ryffel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,31]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063798","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,31]]}}}